SALT LAKE CITY, Nov. 12, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the ...
LifeVantage Corporation beats earnings expectations. Reported EPS is $0.18, expectations were $0.17. Operator: Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to today’s ...
LifeVantage Corporation, a prominent health and wellness company specializing in activating health processes at the cellular level, announced that it will release its financial results for the third ...
SALT LAKE CITY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the ...
Good day, ladies and gentlemen, and thank you for standing by. Welcome to today’s conference call to discuss LifeVantage’s Second Quarter of Fiscal 2025 Results. At this time, all participants are in ...
(MENAFN- GlobeNewsWire - Nasdaq) New in vitro research shows P84 influences key gut peptides – including one by more than 1,000% – supporting cellular pathways tied to regulation, repair, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback